Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Investing in your 20s can set the foundation for a secure retirement. Discover the best options to maximize your growth.
17,680 articlesA major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Seeking dependable income in a volatile market? This article highlights three energy dividend stocks reliable for 202...
When regulators and exchanges join forces to reverse a settlement, it signals a new chapter in crypto enforcement. Th...
Broadcom's June earnings could upend market expectations. This deep-dive explains why the report may matter more than...
Oracle delivered a dramatic rise in May as it pivots toward AI cloud infrastructure. This article breaks down the dri...
Alphabet's plan to issue new stock could dilute existing holders. This deep dive explains what that means for investo...
A recent insider move at Precigen has many investors asking if a CFO’s share sale signals trouble. This deep-dive bre...
Insider moves can reveal a lot about a company's near-term strategy, but they rarely tell the whole story. This guide...
A real-world look at a funding controversy that affected a community food program and what it means for donors and ho...
MP Materials stands at the crossroads of national strategy and market demand for critical minerals. This guide outlin...
The crypto world pivoted last week as a regulator-approved platform hit a $1 billion weekly volume in perpetual futur...
Imagine the next 10 years of your portfolio. This piece explains why Costco's shine may not translate into a top inve...